Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 3, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aclaris Therapeutics, Inc.
| 6.24K |
$1.26 | -$4,062.24 | +0.49% | 1.29M |
Apr 1
| |||||||
Aclaris Therapeutics, Inc.
| 6.24K |
$1.24 | -$3,996.52 | +0.49% | 1.28M |
Mar 1
| |||||||
Aclaris Therapeutics, Inc.
| 52.14K |
$1.24 | -$26,390.92 | +38.73% | 186.78K |
Mar 1 - Mar 2
| |||||||
Aclaris Therapeutics, Inc.
| 3.56K |
$1.24 | -$1,757.08 | +17.42% | 23.98K |
Mar 1 - Mar 2
| |||||||
Aclaris Therapeutics, Inc.
| 14.5K |
$1.24 | $17,955.00 | +100.95% | 28.86K |
Mar 1 - Mar 4
| |||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
Aclaris Therapeutics, Inc.
| 4.92K |
$1.20 | -$3,099.60 | +3.79% | 134.64K |
Feb 1
| |||||||
Aclaris Therapeutics, Inc.
| 12.33K |
$1.20 | -$7,705.20 | +56.85% | 34.02K |
Feb 1
| |||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
Aclaris Therapeutics, Inc.
| 4.96K |
$1.05 | -$2,662.80 | +32.11% | 20.43K |
Jan 1
| |||||||
Aclaris Therapeutics, Inc.
| 17.88K |
$1.05 | -$9,581.25 | +74.67% | 41.81K |
Jan 1
| |||||||
Aclaris Therapeutics, Inc.
| -6.00K |
$5.08 | -$30,460.20 | -4.42% | 129.72K |
Oct 23
|
Scheduled
| ||||||
Aclaris Therapeutics, Inc.
| 9.49K |
$7.90 | $74,971.00 | +158.93% | 15.46K |
Sep 6
| |||||||
Aclaris Therapeutics, Inc.
| 715 |
$7.90 | -$2,251.50 | +13.60% | 5.97K |
Sep 1
| |||||||
Aclaris Therapeutics, Inc.
| 14.71K |
$6.80 | $99,958.71 | +210.58% | 21.69K |
Aug 28
| |||||||
Aclaris Therapeutics, Inc.
| -6.00K |
$7.32 | -$43,894.80 | -4.23% | 135.72K |
Aug 21
| |||||||
Aclaris Therapeutics, Inc.
| 11.14K |
$9.81 | -$43,526.97 | +87.02% | 23.94K |
Aug 1
| |||||||
Aclaris Therapeutics, Inc.
| 9.59K |
$10.37 | -$56,070.59 |
∞
| 9.59K |
Jul 1
| |||||||
Aclaris Therapeutics, Inc.
| 16.5K |
$1.41 | $23,265.00 | +51.56% | 48.5K |
Jun 20
| |||||||
Aclaris Therapeutics, Inc.
| -6.00K |
$10.28 | -$61,662.60 | -4.06% | 141.72K |
Jun 20
| |||||||
Aclaris Therapeutics, Inc.
| 249 |
$1.36 | $337.68 | +0.78% | 32K |
Jun 15
| |||||||
Aclaris Therapeutics, Inc.
| 4.51K |
—
|
—
| +23.04% | 24.07K |
Jun 1 - Jun 2
| |||||||
Aclaris Therapeutics, Inc.
| 4.51K |
—
|
—
| +134.30% | 7.86K |
Jun 1 - Jun 2
| |||||||
Aclaris Therapeutics, Inc.
| 4.51K |
—
|
—
| +57.83% | 12.3K |
Jun 1 - Jun 2
| |||||||
Aclaris Therapeutics, Inc.
| 4.51K |
—
|
—
| +16.54% | 31.75K |
Jun 1 - Jun 2
| |||||||
Aclaris Therapeutics, Inc.
| 4.51K |
—
|
—
| +23.04% | 24.07K |
Jun 1 - Jun 2
| |||||||
Aclaris Therapeutics, Inc.
| 4.51K |
—
|
—
|
∞
| 4.51K |
Jun 1 - Jun 2
| |||||||
Aclaris Therapeutics, Inc.
| 4.51K |
—
|
—
| +45.73% | 14.36K |
Jun 1 - Jun 2
| |||||||
Aclaris Therapeutics, Inc.
| 4.51K |
—
|
—
| +13.18% | 38.7K |
Jun 1 - Jun 2
| |||||||
Aclaris Therapeutics, Inc.
| 6.3K |
$7.86 | $49,532.49 | +96.92% | 12.8K |
Mar 17
| |||||||
Aclaris Therapeutics, Inc.
| 6.5K |
$7.74 | $50,277.50 |
∞
| 6.5K |
Mar 9
| |||||||
Aclaris Therapeutics, Inc.
| 97.44K |
$12.50 | -$740,658.20 | +8.29% | 1.27M |
Mar 1 - Mar 3
| |||||||
Aclaris Therapeutics, Inc.
| 56.34K |
$12.51 | -$385,638.87 | +61.65% | 147.72K |
Mar 1 - Mar 3
| |||||||
Aclaris Therapeutics, Inc.
| 4.56K |
$12.45 | -$23,578.52 | +650.86% | 5.26K |
Mar 1 - Mar 3
| |||||||
Aclaris Therapeutics, Inc.
| -5.00K |
$13.06 | -$65,310.50 | -5.19% | 91.39K |
Feb 15
|
Scheduled
| ||||||
Aclaris Therapeutics, Inc.
| -4.27K |
$13.89 | -$59,272.47 | -37.93% | 6.98K |
Feb 8
| |||||||
Aclaris Therapeutics, Inc.
| -30.00K |
$16.66 | -$499,922.79 | -2.49% | 1.18M |
Feb 1 - Feb 2
|
Scheduled
| ||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
Aclaris Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.